Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing Inhaled Corticosteroid Adherence and Responsiveness in Severe Asthma Using Beclometasone Dipropionate/Formoterol NEXThaler Dose-Counting and Nitric Oxide Monitoring.
Aung HWW, Boddy CE, Hampson E, Bell M, Parnell LA, Balasundaram K, Murphy AC, Naveed S, Bradding P. Aung HWW, et al. Among authors: bradding p. J Allergy Clin Immunol Pract. 2024 Jun;12(6):1539-1546.e5. doi: 10.1016/j.jaip.2024.03.026. Epub 2024 Mar 20. J Allergy Clin Immunol Pract. 2024. PMID: 38518866
The role of the mast cell in the pathophysiology of asthma.
Bradding P, Walls AF, Holgate ST. Bradding P, et al. J Allergy Clin Immunol. 2006 Jun;117(6):1277-84. doi: 10.1016/j.jaci.2006.02.039. Epub 2006 Apr 27. J Allergy Clin Immunol. 2006. PMID: 16750987 Review.
Increased sputum and bronchial biopsy IL-13 expression in severe asthma.
Saha SK, Berry MA, Parker D, Siddiqui S, Morgan A, May R, Monk P, Bradding P, Wardlaw AJ, Pavord ID, Brightling CE. Saha SK, et al. Among authors: bradding p. J Allergy Clin Immunol. 2008 Mar;121(3):685-91. doi: 10.1016/j.jaci.2008.01.005. J Allergy Clin Immunol. 2008. PMID: 18328894 Free PMC article.
Effectiveness of voriconazole in the treatment of Aspergillus fumigatus-associated asthma (EVITA3 study).
Agbetile J, Bourne M, Fairs A, Hargadon B, Desai D, Broad C, Morley J, Bradding P, Brightling CE, Green RH, Haldar P, Pashley CH, Pavord ID, Wardlaw AJ. Agbetile J, et al. Among authors: bradding p. J Allergy Clin Immunol. 2014 Jul;134(1):33-9. doi: 10.1016/j.jaci.2013.09.050. Epub 2013 Nov 28. J Allergy Clin Immunol. 2014. PMID: 24290286 Clinical Trial.
Outcomes after cessation of mepolizumab therapy in severe eosinophilic asthma: a 12-month follow-up analysis.
Haldar P, Brightling CE, Singapuri A, Hargadon B, Gupta S, Monteiro W, Bradding P, Green RH, Wardlaw AJ, Ortega H, Pavord ID. Haldar P, et al. Among authors: bradding p. J Allergy Clin Immunol. 2014 Mar;133(3):921-3. doi: 10.1016/j.jaci.2013.11.026. Epub 2014 Jan 10. J Allergy Clin Immunol. 2014. PMID: 24418480 Clinical Trial. No abstract available.
Protocol for a feasibility study to inform the development of a multicentre randomised controlled trial of asthma-tailored pulmonary rehabilitation versus usual care for individuals with severe asthma.
Majd S, Apps LD, Hudson N, Hewitt S, Eglinton E, Murphy A, Bradding P, Singh S, Green R, Evans R. Majd S, et al. Among authors: bradding p. BMJ Open. 2016 Mar 23;6(3):e010574. doi: 10.1136/bmjopen-2015-010574. BMJ Open. 2016. PMID: 27009149 Free PMC article. Clinical Trial.
241 results